MG

(redirected from myasthenia)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to myasthenia: Ocular myasthenia

MG

The two-character ISO 3166 country code for MADAGASCAR.

MG

1. ISO 3166-1 alpha-2 code for the Republic of Madagascar. This is the code used in international transactions to and from Malagasy bank accounts.

2. ISO 3166-2 geocode for Madagascar. This is used as an international standard for shipping to Madagascar. Each Malagasy province has its own code with the prefix "MG." For example, the code for the Province of Toamasina is ISO 3166-2:MG-A.
References in periodicals archive ?
Combined operation for myasthenia gravis and coronary artery disease.
A quarter of our members told us they really needed a myasthenia nurse last year and there wasn't one available in their area.
In conclusion, we describe a case of anti-MuSK myasthenia gravis associated with acute HEV in a young, immunocompetent patient in France.
Since cytotoxic T lymphocytes play an important role in the destruction of tumor and cancer cells, thymectomized myasthenia gravis patients may be more susceptible to cancer development.
Following confirmation of acquired myasthenia gravis, a treatment plan will be made.
Severity of MG was evaluated by the Osserman and Genkins Classification (stage I: ocular; stage IIA: mildly generalized, no crisis; stage IIB: moderately generalized, inadequate treatment response, bulbar involvement, no crisis; stage III: acute fulminant myasthenia, profound symptoms with respiratory crisis, no response to treatment, high mortality; stage IV: late and profound myasthenia with same findings as stage III) (12).
International Conference on Myasthenia Gravis and Related Disorders (12th: 2012: New York, NY) Ed.
OCTOBER WILL mark the first-ever Ocular Myasthenia Awareness Month.
Myasthenia Gravis (MG) is an auto-immune disease, which causes fluctuating muscle weakness - it is often known as the rag doll disease because it leaves sufferers tired and listless.
Drugs that increase choline transporter activity could represent a novel therapeutic strategy for myasthenia gravis and a wide range of other disorders that involve cholinergic signaling deficits, said Blakely.
9 million to support research and development of CK-2017357, a fast skeletal muscle troponin activator, directed to the potential treatment for myasthenia gravis.